Manan Lahoty, capital markets practice head at IndusLaw is leaving the firm with his team of eight partners and 40 associates to join Cyril Amarchand Mangaldas.
The partners moving with Lahoty are Abhiroop Lahiri, Abhyuday Bhotika, Anshul Roy, Manshoor Nazki, Priyadarshini Rao, Puneet Passi, Ravi Dubey, Vishal Yaduvanshi. Lahiri, Nazki, Dubey and Yaduvanshi had previously moved with Lahoty when he left Luthra and Luthra to work at IndusLaw in 2019. At the time, he was also joined by 12 associates.
Commenting on his departure, IndusLaw founding partners Gaurav Dani and Suneeth Katarki said, “While it is a loss, we wish the team well. In the industry, all major firms including IndusLaw are fighting for talent and we are having to deal with it like other firms. We look forward to maintaining a cordial relationship and collaborating in the future.”
In turn, Lahoty thanked IndusLaw for the firm’s support during his time there.
Yash J Ashar, who was promoted to senior partner at the firm since 1 April 2024, will continue to be an integral and core part of the capital markets partners bench at CAM.
Aside from initially supporting Lahoty with the transition, Ashar will also be a member of the firm’s Partnership Council (managing committee), handling client matters and managing key relationships of the firm within capital markets.
Lahoty is widely known for his acumen in the capital markets practice. In 2023, he was made part of IndusLaw’s management committee, which includes the founding partners. He started his career at the erstwhile Amarchand Mangaldas in 2002, moved to Luthra in 2006, and later worked at Shearman & Sterling in 2007. In 2009, he made it back to Luthra as a partner and this time stayed for a decade, only to leave in 2019 for IndusLaw.
Lahoty is qualified to practise in both England and Wales, and India. He has played a key role in some of India’s most significant capital market transactions, such as the public offerings of Coal India and Zomato, the CPSE Exchange Traded Fund, and Daiichi’s stake sale in Sun Pharmaceutical. He advises leading domestic and international investment banks on securities law matters, including pre-offering corporate restructuring and corporate governance.
